SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 52 filers reported holding SCPHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $238,000 | -8.1% | 38,891 | 0.0% | 0.05% | -18.0% |
| Q1 2021 | $259,000 | +25.7% | 38,891 | 0.0% | 0.06% | 0.0% |
| Q4 2020 | $206,000 | -69.6% | 38,891 | -57.2% | 0.06% | -72.3% |
| Q3 2020 | $677,000 | -8.0% | 90,900 | -9.1% | 0.22% | +3.8% |
| Q2 2020 | $736,000 | +6.4% | 100,000 | +79.1% | 0.21% | -37.1% |
| Q1 2018 | $692,000 | -41.7% | 55,844 | -43.1% | 0.34% | -47.3% |
| Q4 2017 | $1,186,000 | – | 98,100 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 3,831,474 | $20,268,000 | 6.83% |
| AIGH Capital Management LLC | 637,322 | $3,372,000 | 1.37% |
| Worth Venture Partners, LLC | 162,875 | $862,000 | 0.68% |
| Ikarian Capital, LLC | 1,466,147 | $7,756,000 | 0.34% |
| RA Capital Management | 3,518,998 | $18,615,000 | 0.26% |
| Orbimed Advisors | 4,797,148 | $25,377,000 | 0.22% |
| DAFNA Capital Management LLC | 38,891 | $206,000 | 0.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 150,699 | $797,000 | 0.03% |
| Alyeska Investment Group, L.P. | 355,690 | $1,882,000 | 0.03% |
| ALGERT GLOBAL LLC | 13,860 | $73,000 | 0.02% |